AJNR 10:1171-1179, November/December 1989; AJR 154: February 1990 Leptomeningeal metastasis, previously known as meningeal carcinomatosis or carcinomatous meningitis, is a relatively uncommon mode of tumor spread. It may arise hematogenously through the meningeal vessels from the systemic neoplasms or from the shedding of tumor cells in certain primary CNS neoplasms. It often presents as diffuse or disseminated infiltration in the intracranial and intraspinal subarachnoid space. The intracranial abnormalities related to leptomeningeal metastasis on CT have been thoroughly described by Enzman et al. [1] and Lee et al. [2] . The four major CT abnormalities are (1) sulcal-cisternal enhancement, (2) ependymal enhancement, (3) widened irregular tentorial enhancement, and (4) communicating hydrocephalus.
Occasionally, collections of tumor cells can be loculated in the dependent or generous portions of the intracranial subarachnoid space, including the ventricles, forming a rather distinct extraaxial mass lesion. This phenomenon, when it occurs without diffuse pattern, may cause a diagnostic dilemma and delay proper management. Intracranial loculated leptomeningeal metastases, however, have never been well documented in the literature. The purpose of this retrospective study is to identify and categorize these less familiar patterns of leptomeningeal metastasis in order to improve diagnostic acumen and direct proper management.
Materials and Methods
Records of 25 cancer patients with leptomeningeal metastases manifested by loculated intracranial abnormalities on CT and/or MR were collected for this retrospective study. The AJNR: 1 0, November/December 1989 diagnosis was confirmed by CSF cy1ology alone in 14 patients, by surgery alone in three patients, and by CSF cytology and surgery in two patients. Diagnosis in the remaining six patients was not confirmed histologically by CSF cytology, owing to the intracranial mass effect, nor by surgery. All 25 patients had CT studies on various scanners before and after IV contrast administration; the scan thickness varied from 5 mm to 1 0 mm. Twenty patients were studied by MR (the majority on a 1.5-T GE scanner). The MR technical parameters included slice thickness of 5 mm with a 1-2.5-mm interslice gap, 256 x 128 matrix, 24-cm field of view, and 2-4 excitations.
Sagittal and axial scans were obtained in all patients, supplemented with coronal views in selected cases. Spin-echo pulse sequences with a long TR (2000) and short and long TEs (20/80) were obtained in addition to T1-weighted images (SOQ-800/20-30). The most recent seven patients also had enhanced MR after IV administration of Gd-DTPA.
The size, site, and number of loculated leptomeningeal metastases were recorded. The CT attenuation coefficient of the lesions was compared with the normal cortex (i.e., hypodense, isodense, and hyperdense). The MR signal intensity was described as hyperintense, 
Results
The appearances of loculated leptomeningeal metastases are summarized in Table 1 . All lesions were isodense or slightly hyperdense on the precontrast CT scans and had moderate to marked enhancement on postcontrast scans (Fig. 1 ). On the unenhanced MR studies, all lesions were hypointense or isointense on T1-weighted images and demonstrated brighter signal intensity than surrounding CSF and brain tissue on long TRfshort TE images; the lesions often became obscured on T2-weighted images because of the hyperintensity of CSF (Fig. 2) . Gd-DTPA-enhanced T1-weighted images were obtained in seven patients, and all showed marked enhancement of tumors (Figs. 2 and 3) .
The size, number, and anatomic site of the loculated metastases as well as the primary tumors are detailed in Table  2 . The most frequent underlying primary tumors were medulloblastoma (eight cases), malignant glioma (four cases), and squamous cell carcinoma of the lung (three cases). The size of the lesions varied from 5 mm to 8 em in diameter. The configuration was often round or dome-shaped except when infiltrating into the perineural CSF space alongside a cranial nerve. The ependymal lesions tenaed to be small and multiple. The most frequent locations were the suprasellar cistern (eight cases), lateral ventricles (five cases), lateral recess of the fourth ventricle (five cases), cerebellopontine angle cistern (four cases), and fourth ventricle (three cases).
From the morphologic location of the loculated masses, four distinctive subgroups were identified as follows: type A, mass(es) limited to the subarachnoid space (Fig. 4) ; type B, subarachnoid mass(es) with minor parenchymal infiltration but without parenchymal edema (Fig. 5) ; type C, subarachnoid space mass(es) with edema (Fig. 6) ; and type D, mass(es) growing along the perineural CSF space and presenting as (Fig. 7) . The type A pattern, observed in 12 patients, was the most frequent. Five of these 12 also had a diffuse pattern of leptomeningeal metastasis. Type B was seen in five patients, and type C in three. Two cases of type D were identified. Two patients presented with combined types A and C, and one patient had combined types B and C.
Contrast-enhanced CT was better than unenhanced MR in defining the location and extent of loculated leptomeningeal metastases in all cases (Fig. 8) . However, in the seven cases in which comparisons were available, Gd-DTPA-enhanced T1-weighted MR was far superior to contrast-enhanced CT in demonstrating the loculated lesions and in detecting additional subtle diffuse leptomeningeal metastases (Fig. 9) .
Discussion
Leptomeningeal metastasis tends to be diffuse in both the intracranial and intraspinal subarachnoid spaces. Intracranially, the lesions are often more severe in the dependent portions of the cranial fossae or in areas where there are abundant CSF collections, such as the suprasellar cisterns, the cerebellopontine angle cisterns, and the ventricles. Microscopically, the tumor cells infiltrate the leptomeninges as a single layer or as thicker, multilayered aggregates. The earliest infiltration is along cortical vessels and is limited to the perivascular Virchow-Robin spaces. There is no transgression of the pia [3] . Most of these lesions are too small to be detected by currently available radiologic imaging techniques. When the tumor cells form larger aggregates, they may appear as a plaquelike coating on the surface of the brain, in the cisterns and fissures, along the tentorium, and/or on the mass and 2.5-em subependymal mass with edema ependymal lining of the ventricles. They can then be detected with contrast-enhanced CT [1, 2] . Occasionally, a mass of tumor accumulates in certain dependent locations where there is widening of the subarachnoid space. A subarachnoid extraaxial mass subsequently forms (type A) (Fig. 1 0) . Further tumor growth leads to incursion into the under1ying brain parenchyma while the main bulk of tumor remains in the subarachnoid space. At this stage the borders between loculated subarachnoid tumor and parenchymal infiltration become indistinct (type B) (FIQ. 11 ). However, the degree of parenchymal infiltration is not severe enough to cause significant vasogenic edema in the brain A, Noncontrast CT scan shows multilobulated bifrontal isodense mass with extensive parenchymal edema.
B, Contrast-enhanced CT scan shows marked and solid enhancement of this infiltrating metastasis. Note enhanced falx (arrows) within tumor. Surgery revealed large subarachnoid metastasis with extensive transpinal infiltration. A, Contrast·enhanced CT scan shows 1-cm loculated subarachnoid metastasis (type A) in left sylvian fissure (arrow). Positive CSF cytology. B, Contrast·enhanced CT scan 7 months later. Lesion has progressed and associated with vasogenic edema (type C), mimicking parenchymal lesion. C, Coronal Gd-DTPA-enhanced T1-weighted MR image (600/30) better demonstrates tumor growth along sylvian fissure into brain parenchyma.
parenchyma. When parenchymal infiltration becomes extensive and spreads farther away from the pial surface, the tumor loses its distinct extraaxial character and mimics a parenchymal tumor, particularly in the presence of associated parenchymal vasogenic edema (type C) (Figs. 12 and 13) . The most unusual loculated proliferation of leptomeningeal metastases is characterized by tumor cells trapped and growing in the invaginated subarachnoid space accompanying the cranial nerve(s) (type D). Further outgrowth of tumor may extend under the Schwann cell sheath of cranial nerves into the extradural space. This appearance may be misdiagnosed as cranial nerve neurilemoma (schwannoma). The lesion may also mimic an optic glioma if the optic nerve is involved. This rare type of loculated leptomeningeal metastases had been noted at autopsy [4] but has not been documented in the radiologic literature [5, 6] .
The loculated patterns of leptomeningeal metastasis are often observed as isolated lesions. In our series, only five (20%) of 25 cases were seen with diffuse leptomeningeal metastasis. Not infrequently, the loculated leptomeningeal metastasis was present as a single lesion (14/25, 56%). However, ependymal lesions along the ventricular wall tend to be multiple.
Abnormal leptomeningeal contrast enhancement is nonspecific for leptomeningeal metastases and results from any entity causing blood-meningeal barrier abnormalities or increased leptomeningeal vascularity [7 -9] . It can be appreciated on both CT and MR. However, in animal studies, MR has been more revealing than CT [8] . Our study indicates that multiplanar MR is far superior to CT, not only in delineating the exact location and extent of the loculated leptomeningeal metastases but also in detecting small plaquelike seedings undetected by CT. Gd-DTPA-enhanced T1-weighted MR appears to be the method of choice for imaging both loculated and diffuse leptomeningeal metastases.
